Medtronic recalls insulin infusion sets


Medtronic logoMedtronic (NYSE:MDT) said today that it’s recalling some of the infusion sets used with its insulin pumps due to problems with a discontinued component.

The Fridley, Minn.-based medical device titan said the problem involves a vent membrane that’s susceptible to blockage during priming and fill-tubing. No pumps or glucose sensors are affected by the recall, Medtronic said, and infusion sets made since April 2017 use an updated vent membrane design.

Get the full story on our sister site Drug Delivery Business News.


Want to stay on top of MDO content? Subscribe to our e-newsletter.

Speak Your Mind